Correction: Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Huismans Maarten A, Gort Eelke H, van der Heijden Lisa T, Guven Mese Sermin M, Klein Wolterink Helena M, Braat Manon N G J A, Elias Sjoerd G, de Vos Filip Y F L, Devriese Lot A, Verheul Henk M W, Opdam Frans L, Koopman Miriam, Nienhuis Hilde H, Crommelin Heleen A, Snippert Hugo J G, Huitema Alwin D R, Roodhart Jeanine M L

Аннотация